A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group study (Q59647333)
Jump to navigation
Jump to search
scientific article published on 01 November 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group study |
scientific article published on 01 November 2002 |
Statements
A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group study (English)
R G Tozer
S Burdette-Radoux
K Berlanger
M L Davis
R C Lohmann
J R Rusthoven
N Wainman
L Seymour
National Cancer Institute of Canada Clinical Trials Group
1 November 2002
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference